MARKET

BAX

BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

82.24
-1.85
-2.20%
After Hours: 82.24 0 0.00% 17:01 06/11 EDT
OPEN
84.25
PREV CLOSE
84.09
HIGH
84.50
LOW
82.12
VOLUME
6.11M
TURNOVER
--
52 WEEK HIGH
91.45
52 WEEK LOW
74.79
MARKET CAP
41.35B
P/E (TTM)
39.71
1D
5D
1M
3M
1Y
5Y
Top stocks with pricing power for a sputtering reflation trade: Alpha Tactics
Wall Street got the hot consumer inflation data it expected this past week, but the reaction of the stock and bond markets underscored doubt in the reflation trade.The CPI showed
Seekingalpha · 11h ago
Baxter International Inc. stock underperforms Friday when compared to competitors
marketwatch.com · 1d ago
Baxter International Inc. stock outperforms market on strong trading day
marketwatch.com · 2d ago
Baxter International Inc. stock rises Wednesday, outperforms market
marketwatch.com · 3d ago
Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive
Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.
Zacks · 3d ago
Baxter International Inc. stock outperforms competitors despite losses on the day
marketwatch.com · 4d ago
Baxter Presents Data at 58th ERA-EDTA Congress Indicating Theranova May Reduce Cardiovascular Events and Hospitalizations
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing expanded hemodialysis (HDx) therapy enabled by the Theranova dialyzer may reduce cardiovascular events by 35% and hospitalization rates by 18% accordin...
Business Wire · 4d ago
Baxter International Inc. stock falls Monday, underperforms market
Shares of Baxter International Inc. slipped 1.20% to $81.26 Monday, on what proved to be an all-around grim trading session for the stock market, with the...
marketwatch.com · 5d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BAX. Analyze the recent business situations of Baxter Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BAX stock price target is 94.00 with a high estimate of 99.00 and a low estimate of 85.00.
EPS
Institutional Holdings
Institutions: 1.49K
Institutional Holdings: 463.00M
% Owned: 92.08%
Shares Outstanding: 502.85M
TypeInstitutionsShares
Increased
315
28.29M
New
77
1.78M
Decreased
417
22.10M
Sold Out
91
1.43M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jose Almeida
Chief Financial Officer/Executive Vice President
James Saccaro
Senior Vice President/General Counsel
Sean Martin
Senior Vice President/Director of Human Resources
Jeanne Mason
Senior Vice President
Giuseppe Accogli
Senior Vice President
James Borzi
Senior Vice President
Cristiano Franzi
Senior Vice President
Andrew Frye
Senior Vice President
Jacqueline Kunzler
Lead Director/Independent Director
Albert Stroucken
Independent Director
Thomas Chen
Independent Director
John Forsyth
Independent Director
Peter Hellman
Independent Director
Michael Mahoney
Independent Director
Patricia Morrison
Independent Director
Stephen Oesterle
Independent Director
Cathy Smith
Independent Director
Thomas Stallkamp
Independent Director
Amy Wendell
Independent Director
David Wilkes
Declaration Date
Dividend Per Share
Ex-Div Date
05/03/2021
Dividend USD 0.28
06/03/2021
02/16/2021
Dividend USD 0.245
02/25/2021
11/16/2020
Dividend USD 0.245
12/03/2020
07/14/2020
Dividend USD 0.245
08/28/2020
05/05/2020
Dividend USD 0.245
06/04/2020
02/18/2020
Dividend USD 0.22
02/27/2020
11/19/2019
Dividend USD 0.22
12/05/2019
07/16/2019
Dividend USD 0.22
08/29/2019
05/07/2019
Dividend USD 0.22
06/06/2019
02/19/2019
Dividend USD 0.19
02/28/2019
11/13/2018
Dividend USD 0.19
11/30/2018
07/17/2018
Dividend USD 0.19
08/30/2018
05/08/2018
Dividend USD 0.19
05/31/2018
02/20/2018
Dividend USD 0.16
03/01/2018
11/14/2017
Dividend USD 0.16
11/30/2017
07/18/2017
Dividend USD 0.16
08/30/2017
05/02/2017
Dividend USD 0.16
05/31/2017
02/21/2017
Dividend USD 0.13
03/01/2017
11/08/2016
Dividend USD 0.13
11/30/2016
07/19/2016
Dividend USD 0.13
08/31/2016
  • All
  • Financials
  • Insiders
More
About BAX
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.